FATAL SEPSIS FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN ADMINISTRATION FOR BLADDER-CANCER

被引:103
|
作者
RAWLS, WH
LAMM, DL
LOWE, BA
CRAWFORD, ED
SAROSDY, MF
MONTIE, JE
GROSSMAN, HB
SCARDINO, PT
机构
[1] UNIV BAYLOR,DEPT UROL,HOUSTON,TX
[2] UNIV OREGON,HLTH SCI CTR,DEPT UROL,EUGENE,OR 97403
[3] UNIV COLORADO,DEPT UROL,DENVER,CO 80202
[4] UNIV TEXAS,HLTH SCI CTR,DEPT UROL,SAN ANTONIO,TX 78284
[5] CLEVELAND CLIN EDUC FDN,DEPT UROL,CLEVELAND,OH 44106
[6] UNIV MICHIGAN,MED CTR,DEPT UROL,ANN ARBOR,MI 48109
来源
JOURNAL OF UROLOGY | 1990年 / 144卷 / 06期
关键词
D O I
10.1016/S0022-5347(17)39731-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial bladder cancer. Complications from bacillus Calmette-Guerin therapy are usually minor but serious and even fatal reactions can occur. Five recent cases illustrate the gravity of bacillus Calmette-Guerin sepsis. One man with severe debility and the organic brain syndrome died acutely with a fever of 40°C. Two men had frank sepsis that progressed to multiorgan failure and death. Sepsis progressed despite the use of isoniazid, rifampin and streptomycin. Two men who had equally progressive sepsis with intravesical bacillus Calmette-Guerin survived with the use of cycloserine for the first 72 hours of treatment. Triple anticuberculous antibiotics, including cycloserine, may be lifesaving. Sepsis resulted from intravenous absorption through inflamed or disrupted urothelium. Bacillus Calmette-Guerin treatment should not be administered in the presence of severe cystitis or after grossly traumatic catheterization.
引用
收藏
页码:1328 / 1330
页数:3
相关论文
共 50 条
  • [1] PROSPECTIVE RANDOMIZED COMPARISON OF INTRAVESICAL WITH PERCUTANEOUS BACILLUS CALMETTE-GUERIN VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN IN SUPERFICIAL BLADDER-CANCER
    LAMM, DL
    DEHAVEN, JI
    SHRIVER, J
    SAROSDY, MF
    [J]. JOURNAL OF UROLOGY, 1991, 145 (04): : 738 - 740
  • [2] INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER - EFFECT OF BACILLUS CALMETTE-GUERIN VIABILITY ON TREATMENT RESULTS
    KELLEY, DR
    RATLIFF, TL
    CATALONA, WJ
    SHAPIRO, A
    LAGE, JM
    BAUER, WC
    HAAFF, EO
    DRESNER, SM
    [J]. JOURNAL OF UROLOGY, 1985, 134 (01): : 48 - 53
  • [3] SYSTEMIC BACILLUS CALMETTE-GUERIN INFECTION, BCGITIS, IN PATIENTS TREATED BY INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR BLADDER-CANCER
    STEG, A
    LELEU, C
    DEBRE, B
    BOCCONGIBOD, L
    SICARD, D
    [J]. EUROPEAN UROLOGY, 1989, 16 (03) : 161 - 164
  • [4] Peritoneal and pulmonary tuberculosis following intravesical administration of Bacillus Calmette-Guerin for bladder cancer
    Uematsu, Riku
    Teishima, Jun
    Sakata, Hiroyuki
    Mita, Yoshie
    Yoshii, Takahiko
    Tashiro, Yuki
    Yao, Akihisa
    Nakamura, Ichiro
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 12 (03) : 221 - 225
  • [5] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY IN BLADDER-CANCER
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (09): : 1238 - 1240
  • [6] BACILLUS CALMETTE-GUERIN IN THE MANAGEMENT OF BLADDER-CANCER
    DROLLER, MJ
    [J]. JOURNAL OF UROLOGY, 1986, 135 (02): : 331 - 333
  • [7] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR BLADDER-CANCER
    LAMM, DL
    [J]. JOURNAL OF UROLOGY, 1985, 134 (01): : 40 - 47
  • [8] Mycobacterial sepsis following intravesical instillation of Bacillus Calmette-Guerin
    Garyfallou, GT
    [J]. ACADEMIC EMERGENCY MEDICINE, 1996, 3 (02) : 157 - 160
  • [9] GRANULOMATOUS PROSTATITIS FOLLOWING BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY OF BLADDER-CANCER
    OATES, RD
    STILMANT, MM
    FREEDLUND, MC
    SIROKY, MB
    [J]. JOURNAL OF UROLOGY, 1988, 140 (04): : 751 - 754
  • [10] Perianal abscess as a complication of intravesical administration of Bacillus Calmette-Guerin for bladder cancer
    Koksal, Aydin Seref
    Bilge, Zulfukar
    Torun, Serkan
    Sasmaz, Nurgul
    Yazicioglu, Ahmet Hamdi
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (02): : 260 - 260